Sun Pharma shares rise as USFDA clears Mohali facility
Sun Pharma said, Its subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status.
Sun Pharma shares closed at Rs 708.25 per piece on BSE, up Rs 24 or 3.61%.
Sun Pharma said, “It's subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status."
The company further said, “This proposed action will clear the path for Sun Pharma to supply approved products from the Mohali facility to the US market, subject to normal US FDA regulatory requirements.”
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.